Brief: ProtoKinetix Announces The Resumption Of Phase 1B Clinical Trials For The Use Of Aagp® Treated Islet Cells In The Treatment Of Type 1 Diabetes22/04/2021 13:26
Brief: Amendments To Protokinetix Aagp® Protocol For Continuation Of Phase 1 Human Trials By The University Of Alberta Submitted To Health Canada13/07/2020 13:39
Last trade - 00:00Last trade - 00:00Last trade - 00:00